PAPER Cederfjäll E, Nilsson N, Sahin G, Chu Y, Nikitidou E, Björklund T, Kordower JH, Kirik D
SEARCH RESULTS
330986 RESULTS
PAPER Homma K, Fujisawa T, Tsuburaya N, Yamaguchi N, Kadowaki H, Takeda K, Nishitoh H, Matsuzawa A, Naguro I, Ichijo H
SOD1 as a Molecular Switch for Initiating the Homeostatic ER Stress Response under Zinc Deficiency.
Mol Cell. 2013 Oct 10;52(1):75-86. PubMed: 24076220PAPER Herbert MK, Eeftens JM, Aerts MB, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM
CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.
Parkinsonism Relat Disord. 2013 Sep 12; PubMed: 24075122PAPER Salvarani C, Hunder GG, Morris JM, Brown RD, Christianson T, Giannini C
Aβ-related angiitis: Comparison with CAA without inflammation and primary CNS vasculitis.
Neurology. 2013 Oct 29;81(18):1596-603. PubMed: 24078731PAPER Schmitt FA, Saxton J, Ferris SH, Mackell J, Sun Y
Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in moderate to severe Alzheimer's disease patients participating in a donepezil study.
Int J Clin Pract. 2013 Oct;67(10):1050-6. PubMed: 24073978PAPER Correia SC, Perry G, Castellani R, Moreira PI
Is exercise-in-a-bottle likely to proffer new insights into Alzheimer's disease?
J Neurochem. 2013 Oct;127(1):4-6. PubMed: 24074055PAPER Wang DB
Monophosphoryl lipid A is an lipopolysaccharide-derived Toll-like receptor 4 agonist which may improve Alzheimer's disease pathology.
Expert Opin Biol Ther. 2013 Dec;13(12):1639-41. PubMed: 24074146PAPER Kitagishi Y, Matsuda S
Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury.
Alzheimers Res Ther. 2013 Sep 26;5(5):42. PubMed: 24074163PAPER Broster LS, Li J, Smith CD, Jicha GA, Schmitt FA, Jiang Y
Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment.
J Clin Exp Neuropsychol. 2013 Nov;35(9):946-59. PubMed: 24074205PAPER Mm S, Gan SH, Ma K
Epigenomic Approach in Understanding Alzheimer's Disease and Type 2 Diabetes Mellitus.
CNS Neurol Disord Drug Targets. 2013 Sep 30; PubMed: 24074446PAPER Kamal MA
Editorial: Current Updates on Association Between Alzheimer's Diseases and Type 2 Diabetes- Volume I.
CNS Neurol Disord Drug Targets. 2013 Sep 18; PubMed: 24074447PAPER Kamal MA, Priyamvada S, Arivarasu NA, Jabir NR, Tabrez S, Greig NH
Linking Alzheimer's Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation.
CNS Neurol Disord Drug Targets. 2013 Sep 18; PubMed: 24074448PAPER Fuller-Thomson E, Kuh D
The healthy migrant effect may confound the link between bilingualism and delayed onset of Alzheimer's disease.
Cortex. 2013 Aug 29; PubMed: 24074458PAPER Lin CH, Chen PK, Chang YC, Chuo LJ, Chen YS, Tsai GE, Lane HY
Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Biol Psychiatry. 2013 Sep 25; PubMed: 24074637PAPER Franzblau M, Gonzales-Portillo C, Gonzales-Portillo GS, Diamandis T, Borlongan MC, Tajiri N, Borlongan CV
Vascular damage: A persisting pathology common to Alzheimer's disease and traumatic brain injury.
Med Hypotheses. 2013 Nov;81(5):842-5. PubMed: 24074832Current Filters
No filters selected